OptiNose Financial Statements From 2010 to 2025
| 0OP Stock | EUR 0.38 0.01 2.70% |
Check OptiNose financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OptiNose's main balance sheet or income statement drivers, such as , as well as many indicators such as . OptiNose financial statements analysis is a perfect complement when working with OptiNose Valuation or Volatility modules.
OptiNose |
OptiNose Company Current Valuation Analysis
OptiNose's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current OptiNose Current Valuation | 257.48 M |
Most of OptiNose's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OptiNose is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, OptiNose has a Current Valuation of 257.48 M. This is 98.21% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all Germany stocks is 98.45% higher than that of the company.
OptiNose Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OptiNose's current stock value. Our valuation model uses many indicators to compare OptiNose value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OptiNose competition to find correlations between indicators driving OptiNose's intrinsic value. More Info.OptiNose is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OptiNose's earnings, one of the primary drivers of an investment's value.About OptiNose Financial Statements
OptiNose stakeholders use historical fundamental indicators, such as OptiNose's revenue or net income, to determine how well the company is positioned to perform in the future. Although OptiNose investors may analyze each financial statement separately, they are all interrelated. For example, changes in OptiNose's assets and liabilities are reflected in the revenues and expenses on OptiNose's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in OptiNose. Please read more on our technical analysis and fundamental analysis pages.
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. OPTINOSE INC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 204 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in OptiNose Stock
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.